In addition, miR-23a/b treatment was effective in alleviating cGAS-mediated autoinflammatory responses in the Trex1−/− mouse model, indicating that miR-23a/b could be used to treat self DNA-induced autoimmune diseases. Here, CGAS is linked to autoimmune disease.